Inventor · disambiguated record
Amin Mazloom
Also filed as: MAZLOOM AMIN · MAZLOOM AMIN R
14 granted patents·15 pending applications·93 citations·filing 2012–2025
90Inventor score
Top patents by PatentIndex Score
29 records- 0194US8688388B2Methods and processes for non-invasive assessment of genetic variationsSEQUENOM INC·Filed 2012·Granted Apr 1, 2014·63 cites·28 claims
- 0292US10699800B2Methods and processes for non-invasive assessment of genetic variationsSEQUENOM INC·Filed 2014·Granted Jun 30, 2020·8 cites·20 claims
- 0390US11462298B2Methods and processes for non-invasive assessment of genetic variationsSEQUENOM INC·Filed 2020·Granted Oct 4, 2022·2 cites·16 claims
- 0488US10497461B2Methods and processes for non-invasive assessment of genetic variationsSEQUENOM INC·Filed 2013·Granted Dec 3, 2019·7 cites·23 claims
- 0587US11112403B2Assessment of preeclampsia using assays for free and dissociated placental growth factorPROGENITY INC·Filed 2020·Granted Sep 7, 2021·1 cites·20 claims
- 0687US2025006298A1Methods and processes for non-invasive assessment of genetic variationsSEQUENOM INC·Filed 2024·Application pending·0 cites
- 0787US2025244317A1Assessment of preeclampsia using assays for free and dissociated placental growth factorBIORA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0886US11200963B2Genetic copy number alteration classificationsSEQUENOM INC·Filed 2017·Granted Dec 14, 2021·7 cites·19 claims
- 0983US11333672B2Preeclampsia biomarkers and related systems and methodsPROGENITY INC·Filed 2021·Granted May 17, 2022·1 cites·15 claims
- 1083US10482994B2Methods and processes for non-invasive assessment of genetic variationsSEQUENOM INC·Filed 2013·Granted Nov 19, 2019·2 cites·24 claims
- 1181US12112832B2Methods and processes for non-invasive assessment of genetic variationsSEQUENOM INC·Filed 2019·Granted Oct 8, 2024·1 cites·20 claims
- 1277US11327071B2Assessment of preeclampsia using assays for free and dissociated placental growth factorPROGENITY INC·Filed 2021·Granted May 10, 2022·0 cites·18 claims
- 1377US2023052697A1Assessment of preeclampsia using assays for free and dissociated placental growth factorPROGENITY INC·Filed 2022·Application pending·0 cites
- 1476US2024233866A1Methods for non-invasive assessment of genetic variationsSEQUENOM INC·Filed 2024·Application pending·0 cites
- 1576US2024290423A1Methods for non-invasive assessment of genetic alterationsSEQUENOM INC·Filed 2024·Application pending·0 cites
- 1675US2022415435A1Methods and processes for non-invasive assessment of genetic variationsSEQUENOM INC·Filed 2022·Application pending·0 cites
- 1774US11694768B2Methods and processes for assessment of genetic variationsSEQUENOM INC·Filed 2018·Granted Jul 4, 2023·1 cites·20 claims
- 1874US2024029826A1Methods and Processes for Assessment of Genetic VariationsSEQUENOM INC·Filed 2023·Application pending·0 cites
- 1972US2023187021A1Methods for Non-Invasive Assessment of Genomic InstabilitySEQUENOM INC·Filed 2022·Application pending·0 cites
- 2070US2022268781A1Preeclampsia biomarkers and related systems and methodsPROGENITY INC·Filed 2022·Application pending·0 cites
- 2166US2022093207A1Genetic Copy Number Alteration ClassificationsSEQUENOM INC·Filed 2021·Application pending·0 cites
- 2264US2020160934A1Methods and processes for non-invasive assessment of genetic variationsSEQUENOM INC·Filed 2019·Application pending·0 cites
- 2360US2020264188A1Preeclampsia biomarkers and related systems and methodsPROGENITY INC·Filed 2018·Application pending·0 cites
- 2456US11515003B2Copy number alteration and reference genome mappingSEQUENOM INC·Filed 2017·Granted Nov 29, 2022·0 cites·24 claims
- 2555US2025232836A1Methods and processes for assessment of genetic variationsSEQUENOM INC·Filed 2025·Application pending·0 cites
- 2653US11929145B2Methods for non-invasive assessment of genetic alterationsSEQUENOM INC·Filed 2018·Granted Mar 12, 2024·0 cites·22 claims
- 2753US11929143B2Methods for non-invasive assessment of copy number alterationsSEQUENOM INC·Filed 2018·Granted Mar 12, 2024·0 cites·17 claims
- 2853US2024301492A1Methods of preparing assays, systems, and compositions for determining fetal fractionENUMERA MOLECULAR INC·Filed 2021·Application pending·0 cites
- 2941US2019079097A1Preeclampsia biomarkers and related systems and methodsPROGENITY INC·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Amin Mazloom files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →